Representative Image 
Business

India's Serum Institute to boost vaccine exports gradually, report says

The Serum Institute of India, which produces the AstraZeneca COVID-19 vaccine, will resume small exports via the global vaccine-sharing platform COVAX this month and raise it substantially by January, its head told The Telegraph.

migrator

New Delhi

"Our exports to COVAX will recommence again in October, initially these supplies will be small but by January 2022, once we have satisfied domestic demands – people forget that India is still a lower-middle-income country – we will see large volumes go to COVAX," Chief Executive Adar Poonawalla said.

Visit news.dtnext.in to explore our interactive epaper!

Download the DT Next app for more exciting features!

Click here for iOS

Click here for Android

Will 'liar' Edappadi apologise now: DMK on Santhakulam case verdict

Another PIL on Marina Loop Road shops, Madras HC junks plea

Maoist activist Roopesh walks free after 11 years in jail

SC rejects plea against MHA's circular on Vande Mataram, says it's not mandatory

Job regularisation: JIPMER threaten poll boycott